1. Home
  2. EBS vs ANTA Comparison

EBS vs ANTA Comparison

Compare EBS & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • ANTA
  • Stock Information
  • Founded
  • EBS 1998
  • ANTA 2022
  • Country
  • EBS United States
  • ANTA Singapore
  • Employees
  • EBS N/A
  • ANTA N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • ANTA Investment Bankers/Brokers/Service
  • Sector
  • EBS Health Care
  • ANTA Finance
  • Exchange
  • EBS Nasdaq
  • ANTA Nasdaq
  • Market Cap
  • EBS 359.3M
  • ANTA 294.7M
  • IPO Year
  • EBS 2006
  • ANTA 2025
  • Fundamental
  • Price
  • EBS $8.15
  • ANTA $11.91
  • Analyst Decision
  • EBS Strong Buy
  • ANTA Strong Buy
  • Analyst Count
  • EBS 3
  • ANTA 2
  • Target Price
  • EBS $14.33
  • ANTA $19.25
  • AVG Volume (30 Days)
  • EBS 1.0M
  • ANTA 21.3K
  • Earning Date
  • EBS 11-05-2025
  • ANTA 08-12-2025
  • Dividend Yield
  • EBS N/A
  • ANTA N/A
  • EPS Growth
  • EBS N/A
  • ANTA N/A
  • EPS
  • EBS 2.53
  • ANTA 0.24
  • Revenue
  • EBS $851,600,000.00
  • ANTA $56,997,910.00
  • Revenue This Year
  • EBS N/A
  • ANTA $65.94
  • Revenue Next Year
  • EBS $19.24
  • ANTA $59.39
  • P/E Ratio
  • EBS $3.22
  • ANTA $48.88
  • Revenue Growth
  • EBS N/A
  • ANTA 405.62
  • 52 Week Low
  • EBS $4.02
  • ANTA $10.19
  • 52 Week High
  • EBS $12.73
  • ANTA $27.72
  • Technical
  • Relative Strength Index (RSI)
  • EBS 51.40
  • ANTA N/A
  • Support Level
  • EBS $7.45
  • ANTA N/A
  • Resistance Level
  • EBS $8.62
  • ANTA N/A
  • Average True Range (ATR)
  • EBS 0.40
  • ANTA 0.00
  • MACD
  • EBS -0.10
  • ANTA 0.00
  • Stochastic Oscillator
  • EBS 38.46
  • ANTA 0.00

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.

Share on Social Networks: